Predicting time to dementia using a quantitative template of disease progression

Abstract

Characterization of longitudinal trajectories of biomarkers implicated in sporadic Alzheimer's disease (AD) in decades before clinical diagnosis is important for disease prevention and monitoring.

Document Details

• Document Type: Pub Defense Publication
• Publication Date: Feb 28, 2019
• Source ID: 10.1016/j.dadm.2019.01.005

Entities

People

• Bruno M. Jedynak
• Murat Bilgel
• The Alzheimer’s Disease Neuroimaging Initiative*

Organizations

• AbbVie
• Canadian Institutes of Health Research
• Eisai
• National Institute of Biomedical Imaging and Bioengineering
• National Institute on Aging
• National Institutes of Health
• National Science Foundation Division of Mathematical Sciences
• Portland State University
• United States Department of Defense

Tags

Fields of Study

• Psychology

Readers

• Traumatic Brain Injury (TBI) and Cognitive Aging in the Guam and Border Populations Affected by Alzheimer's Disease and Tau-Associated Dementias.
• Wetland-Land-Environmental Management.